Hematopoietic Stem Cell Transplantation: A Neonatal Perspective.
Document Type
Article
Publication Date
6-2019
Identifier
DOI: 10.1542/neo.20-6-e336
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is indicated in various nonmalignant disorders that arise from genetic, hematopoietic, and immune system defects. Many of the disorders described here have life-threatening consequences in the absence of HSCT, a curative intervention. However, timing and approach to HSCT vary by disorder and optimum results are achieved by performing transplantation before irreversible disease-related morbidity or infectious complications. This article details the principles of HSCT in the very young, lists indications, and explores the factors that contribute to successful outcomes based on transplantation and disease-related nuances. It provides an overview into the HSCT realm from a neonatologist's perspective, describes the current status of transplantation for relevant disorders of infancy, and provides a glimpse into future efforts at improving on current success.
Journal Title
Neoreviews
Volume
20
Issue
6
First Page
336
Last Page
336
MeSH Keywords
Cell- and Tissue-Based Therapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome
Keywords
Cell- and Tissue-Based Therapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Transplantation Conditioning; Homologous Transplantation; Treatment Outcome
Recommended Citation
Hall E, Shenoy S. Hematopoietic Stem Cell Transplantation: A Neonatal Perspective. Neoreviews. 2019;20(6):e336-e345. doi:10.1542/neo.20-6-e336
COinS
